Ceruloplasmin is an endogenous inhibitor of myeloperoxidase

Journal of Biological Chemistry

Volumn 288, Issue 9, 2013, Pages 6465-6477

  Chapman, Anna L P ^a   Mocatta, Tessa J ^a   Shiva, Sruti ^c   Seidel, Antonia ^b   Chen, Brian ^a   Khalilova, Irada ^a   Paumann Page, Martina E ^a   Jameson, Guy N L ^b   Winterbourn, Christine C ^a   Kettle, Anthony J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMINS; COMPOUND I; ENDOGENOUS INHIBITOR; FERRIC ENZYMES; HUMAN PLASMAS; HYPOCHLOROUS ACIDS; INACTIVE COMPOUNDS; KNOCK OUTS; MYELOPEROXIDASE; OXIDANT PRODUCTION; POTENT INHIBITOR; PRODUCTION OF; PROSTHETIC GROUPS; PURIFIED PROTEIN; STRONG OXIDANTS; WILD TYPES;

AMINO ACIDS; CHLORINE COMPOUNDS; FREE RADICALS; HYDROGEN PEROXIDE; PATHOLOGY; PEROXIDES; PORPHYRINS; PROTEINS; PURIFICATION;

ENZYMES;

ASCORBIC ACID; CERULOPLASMIN; CHLORINE; FREE RADICAL; HEME; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; IRON; MYELOPEROXIDASE; TYROSINE;

ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HALOGENATION; INFLAMMATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHAGOSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ANIMALS; ASCORBIC ACID; CERULOPLASMIN; ENZYME INHIBITORS; HUMANS; HYPOCHLOROUS ACID; INFLAMMATION; MICE; MICE, KNOCKOUT; OXIDATION-REDUCTION; PEROXIDASE; PROTEIN BINDING;

EID: 84874774038     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.418970     Document Type: Article

References (74)

1. Kettle, A. J., and Winterbourn, C. C. (1997) Myeloperoxidase. A key regulator of neutrophil oxidant production. Redox Rep. 3, 3-15
2. Davies, M. J., Hawkins, C. L., Pattison, D. I., and Rees, M. D. (2008) Mammalian heme peroxidases. From molecular mechanisms to health implications. Antioxid. Redox Signal. 10, 1199-1234
3. Winterbourn, C. C., and Kettle, A. J. (2013) Redox Reactions and Micro- bial Killing in the Neutrophil Phagosome. Antioxid. Redox Signal. 18, 642-660
4. Klebanoff, S. J., Kettle, A. J., Rosen, H., Winterbourn, C. C., and Nauseef, W. M. (2013) Myeloperoxidase. A front-line defender against phagocytosed microorganisms. J. Leukoc. Biol., in press
5. Nicholls, S. J., and Hazen, S. L. (2009) Myeloperoxidase, modified lipoproteins, and atherogenesis. J. Lipid Res. 50, S346-S351
6. Mocatta, T. J., Pilbrow, A. P., Cameron, V. A., Senthilmohan, R., Frampton, C. M., Richards, A. M., and Winterbourn, C. C. (2007) Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J. Am. Coll. Cardiol. 49, 1993-2000
7. Zhang, R., Brennan, M. L., Fu, X., Aviles, R. J., Pearce, G. L., Penn, M. S., Topol, E. J., Sprecher, D. L., and Hazen, S. L. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286, 2136-2142
8. Thomson, E., Brennan, S., Senthilmohan, R., Gangell, C. L., Chapman, A. L., Sly, P. D., Kettle, A. J., (2010) Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis. Free Radic. Biol. Med. 49, 1354-1360
9. Schraufstätter, I. U., Browne, K., Harris, A., Hyslop, P. A., Jackson, J. H., Quehenberger, O., and Cochrane, C. G. (1990) Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. 85, 554-562
10. Pullar, J. M., Vissers, M. C., and Winterbourn, C. C. (2000) Living with a killer. The effects of hypochlorous acid on mammalian cells. IUBMB Life 50, 259-266
11. Buss, I. H., Senthilmohan, R., Darlow, B. A., Mogridge, N., Kettle, A. J., and Winterbourn, C. C. (2003) 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants. Association with adverse respiratory outcome. Pediatr. Res. 53, 455-462
12. Stamp, L. K., Khalilova, I., Tarr, J. M., Senthilmohan, R., Turner, R., Haigh, R. C., Winyard, P. G., and Kettle, A. J. (2012) Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology 51, 1796-1803
13. Vile, G. F., Rothwell, L. A., and Kettle, A. J. (2000) Initiation of rapid, p53-dependent growth arrest in cultured human skin fibroblasts by reactive chlorine species. Arch. Biochem. Biophys. 377, 122-128
14. Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O.,Hörkkö, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A., and Hazen, S. L. (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176-1184
15. Heinecke, J. W. (2002) Tyrosyl radical production by myeloperoxidase. A phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 177, 11-22
16. Meotti, F. C., Senthilmohan, R., Harwood, D. T., Missau, F. C., Pizzolatti, M. G., and Kettle, A. J. (2008) Myricitrin as a substrate and inhibitor of myeloperoxidase. Implications for the pharmacological effects of flavonoids. Free Radic. Biol. Med. 44, 109-120
17. Winterbourn, C. C., and Kettle, A. J. (2003) Radical-radical reactions of superoxide.Apotential route to toxicity. Biochem. Biophys. Res. Commun. 305, 729-736
18. Meotti, F. C., Jameson, G. N., Turner, R., Harwood, D. T., Stockwell, S., Rees, M. D., Thomas, S. R., and Kettle, A. J. (2011) Urate as a physiological substrate for myeloperoxidase. Implications for hyperuricemia and inflammation. J. Biol. Chem. 286, 12901-12911
19. Travis, J., and Salvesen, G. S. (1983) Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709
20. Segelmark, M., Persson, B., Hellmark, T., and Wieslander, J. (1997) Binding and inhibition of myeloperoxidase (MPO). A major function of ceruloplasmin? Clin. Exp. Immunol. 108, 167-174
21. Sokolov, A. V., Pulina, M. O., Ageeva, K. V., Ayrapetov, M. I., Berlov, M. N., Volgin, G. N., Markov, A. G., Yablonsky, P. K., Kolodkin, N. I., Zakharova, E. T., and Vasilyev, V. B. (2007) Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase. Biochemistry 72, 409-415
22. Griffin, S. V., Chapman, P. T., Lianos, E. A., and Lockwood, C. M. (1999) The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int. 55, 917-925
23. Taylor, J. C., and Oey, L. (1982) Ceruloplasmin. Plasma inhibitor of the oxidative inactivation of α1-protease inhibitor. Am. Rev. Respir. Dis. 126, 476-482
24. Park, Y. S., Suzuki, K., Mumby, S., Taniguchi, N., and Gutteridge, J. M. (2000) Antioxidant binding of caeruloplasmin to myeloperoxidase. Myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact. Free Radic. Res. 33, 261-265
25. Sokolov, A. V., Ageeva, K. V., Pulina, M. O., Cherkalina, O. S., Samygina, V. R., Vlasova, I. I., Panasenko, O. M., Zakharova, E. T., and Vasilyev, V. B. (2008) Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic. Res. 42, 989-998
26. Kettle, A. J., and Winterbourn, C. C. (1994) Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 233, 502-512
27. Shiva, S., Wang, X., Ringwood, L. A., Xu, X., Yuditskaya, S., Annavajjhala, V., Miyajima, H., Hogg, N., Harris, Z. L., and Gladwin, M. T. (2006) Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol. 2, 486-493
28. Wolff, S. P. (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233, 182-189
29. Vissers, M. C., Lee, W.-G., and Hampton, M. B. (2001) Regulation of apoptosis by vitamin C. Specific protection of the apoptotic machinery against exposure to chlorinated oxidants. J. Biol. Chem. 276, 46835-46840
30. Dypbukt, J. M., Bishop, C., Brooks, W. M., Thong, B., Eriksson, H., and Kettle, A. J. (2005) A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic. Biol. Med. 39, 1468-1477
31. Chesney, J. A., Mahoney, J. R., Jr., and Eaton, J. W. (1991) A spectrophotometric assay for chlorine-containing compounds. Anal. Biochem. 196, 262-266
32. Auchère, F., and Capeillère-Blandin, C. (1999) NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase. Biochem. J. 343, 603-613
33. Prütz, W. A., Kissner, R., Koppenol, W. H., and Rüegger, H. (2000) On the irreversible destruction of reduced nicotinamide nucleotides by hypohalous acids. Arch. Biochem. Biophys. 380, 181-191
34. Ximenes, V. F., Maghzal, G. J., Turner, R., Kato, Y., Winterbourn, C. C., and Kettle, A. J. (2010) Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem. J. 425, 285-293
35. Shevchenko, A., Jensen, O. N., Podtelejnikov, A. V., Sagliocco, F., Wilm, M., Vorm, O., Mortensen, P., Shevchenko, A., Boucherie, H., and Mann, M. (1996) Linking genome and proteome by mass spectrometry. Largescale identification of yeast proteins from two dimensional gels. Proc. Natl. Acad. Sci. 93, 14440-14445
36. Sokolov, A. V., Ageeva, K. V., Cherkalina, O. S., Pulina, M. O., Zakharova, E. T., Prozorovskii, V. N., Aksenov, D. V., Vasilyev, V. B., and Panasenko, O. M. (2010) Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin. Chem. Phys. Lipids 163, 347-355
37. Kettle, A. J., and Winterbourn, C. C. (1989) Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode. Biochem. J. 263, 823-828
38. Kettle, A. J., and Winterbourn, C. C. (1991) Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs. Biochem. Pharmacol. 41, 1485-1492
39. Winterbourn, C. C. (1985) Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta 840, 204-210
40. Marquez, L. A., and Dunford, H. B. (1993) Interaction of acetaminophen with myeloperoxidase intermediates. Optimum stimulation of enzyme activity. Arch. Biochem. Biophys. 305, 414-420
41. Northrop, D. B. (1998) On the meaning of Km and V/K in enzyme kinetics. J. Chem. Educ. 75, 1153-1157
42. Ochs, R. S. (2000) Understanding enzyme inhibition. J. Chem. Educ. 77, 1453-1456
43. Auchère, F., Bertho, G., Artaud, I., Girault, J. P., and Capeillère-Blandin, C. (2001) Purification and structure of the major product obtained by reaction of NADPH and NMNH with the myeloperoxidase/hydrogen peroxide/chloride system. Eur. J. Biochem. 268, 2889-2895
44. Dunford, H. B., and Hsuanyu, Y. (1999) Kinetics of oxidation of serotonin by myeloperoxidase compounds I and II. Biochem. Cell Biol. 77, 449-457
45. Harrison, J. E., Araiso, T., Palcic, M. M., and Dunford, H. B. (1980) Compound I of myeloperoxidase. Biochem. Biophys. Res. Commun. 94, 34-40
46. Marquez, L. A., and Dunford, H. B. (1995) Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J. Biol. Chem. 270, 30434-30440
47. Marquez, L. A., Huang, J. T., and Dunford, H. B. (1994) Spectral and kinetic studies on the formation of myeloperoxidase compounds I and II. Roles of hydrogen peroxide and superoxide. Biochemistry 33, 1447-1454
48. Tien, M. (1999) Myeloperoxidase-catalyzed oxidation of tyrosine. Arch. Biochem. Biophys. 367, 61-66
49. Furtmüller, P. G., Zederbauer, M., Jantschko, W., Helm, J., Bogner, M., Jakopitsch, C., and Obinger, C. (2006) Active site structure and catalytic mechanisms of human peroxidases. Arch. Biochem. Biophys. 445, 199-213
50. Kettle, A. J., Gedye, C. A., and Winterbourn, C. C. (1997) The mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem. J. 321, 503-508
51. Tidén, A. K., Sjögren, T., Svensson, M., Bernlind, A., Senthilmohan, R., Auchère, F., Norman, H., Markgren, P. O., Gustavsson, S., Schmidt, S., Lundquist, S., Forbes, L. V., Magon, N. J., Paton, L. N., Jameson, G. N., Eriksson, H., and Kettle, A. J. (2011) 2-Thioxanthines are mechanismbased inactivators of myeloperoxidase that block oxidative stress during inflammation. J. Biol. Chem. 286, 37578-37589
52. Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., and Frei, B. (2000) Myeloperoxidase binds to low-density lipoprotein. Potential implications for atherosclerosis. FEBS Lett. 487, 176-180
53. Zheng, L., Nukuna, B., Brennan, M. L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., Ischiropoulos, H., Smith, J. D., Kinter, M., and Hazen, S. L. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114, 529-541
54. Shao, B., Pennathur, S., and Heinecke, J. W. (2012) Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J. Biol. Chem. 287, 6375-6386
55. Sokolov, A. V., Prozorovskii, V. N., and Vasilyev, V. B. (2009) Study of interaction of ceruloplasmin, lactoferrin, and myeloperoxidase by photon correlation spectroscopy. Biochemistry 74, 1225-1227
56. Walker, F. J., and Fay, P. J. (1990) Characterization of an interaction between protein C and ceruloplasmin. J. Biol. Chem. 265, 1834-1836
57. Vasilyev, V. B. (2010) Interactions of caeruloplasmin with other proteins participating in inflammation. Biochem. Soc. Trans. 38, 947-951
58. Jantschko, W., Fürtmuller, P. G., Zederbauer, M., Neugschwandtner, K., Lehner, I., Jakopitsch, C., Arnhold, J., and Obinger, C. (2005) Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design. Biochem. Pharmacol. 69, 1149-1157
59. Gruys, E., Toussaint, M. J., Niewold, T. A., and Koopmans, S. J. (2005) Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B 6, 1045-1056
60. Da Costa, L. A., García-Bailo, B., Borchers, C. H., Badawi, A., and El- Sohemy, A. (2013) Association between the plasma proteome and serum ascorbic acid concentrations in humans. J. Nutr. Biochem. 24, 396-400
61. Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., and Gitlin, J. D. (1995) Aceruloplasminemia. Molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. 92, 2539-2543
62. Gutteridge, J. M. (1980) Iron-oxygen reactions and their use in clinical chemistry. Med. Lab. Sci. 37, 267-273
63. Bielli, P., and Calabrese, L. (2002) Structure to function relationships in ceruloplasmin. A "moonlighting" protein. Cell Mol. Life Sci. 59, 1413-1427
64. Kim, I. G., Park, S. Y., Kim, K. C., and Yum, J. J. (1998) Thiol-linked peroxidase activity of human ceruloplasmin. FEBS Lett. 431, 473-475
65. Mänttäri, M., Manninen, V., Huttunen, J. K., Palosuo, T., Ehnholm, C., Heinonen, O. P., and Frick, M. H. (1994) Serum ferritin and ceruloplasmin as coronary risk factors. Eur. Heart J. 15, 1599-1603
66. Tang, W. H., Wu, Y., Hartiala, J., Fan, Y., Stewart, A. F., Roberts, R., McPherson, R., Fox, P. L., Allayee, H., and Hazen, S. L. (2012) Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 32, 516-522
67. Ehrenwald, E., Chisolm, G. M., and Fox, P. L. (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93, 1493-1501
68. Stocker, R., and Keaney, J. F., Jr. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478
69. Brennan, M. L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., Nissen, S. E., and Hazen, S. L. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349, 1595-1604
70. Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., Hamm, C. W., and the CAPTURE Investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108, 1440-1445
71. Winterbourn, C. C., Buss, I. H., Chan, T. P., Plank, L. D., Clark, M. A., and Windsor, J. A. (2000) Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit. Care Med. 28, 143-149
72. Bakhautdin, B., Febbraio, M., Goksoy, E., de la Motte, C. A., Gulen, M. F., Childers, E. P., Hazen, S. L., Li, X., and Fox, P. L. (2013) Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut 62, 209-219
73. Naito, Y., Takagi, T., and Yoshikawa, T. (2007) Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J. Gastroenterol. 42, 787-798
74. Jennette, J. C., Falk, R. J., and Gasim, A. H. (2011) Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr. Opin. Nephrol. Hypertens. 20, 263-270